Volume 10, Number 6—June 2004
Research
Antimicrobial Resistance Incidence and Risk Factors among Helicobacter pylori–Infected Persons, United States
Table 3
Resistance of HARP H. pylori isolates by sitea
| Location | No. isolates | Amoxicillin |
Tetracycline |
Clarithromycin |
Metronidazole |
Resistant to 1 agent |
Resistant to >1 agent |
Resistant to >1 agent |
|
|---|---|---|---|---|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | |||
| Atlanta, GA |
37 |
0 |
0 |
7 (19) |
5 (14) |
4 (11) |
4 (11) |
8 |
|
| Nashville, TN |
45 |
1 (2) |
0 |
5 (11) |
5 (11) |
0 (24) |
0 |
11 (22) |
|
| Galveston, TX |
10 |
0 |
0 |
1 (10) |
3 (30) |
0 (40) |
0 |
4 (24) |
|
| Philadelphia, PA |
41 |
1 (2) |
0 |
6 (15) |
15 (37) |
16 (39) |
3 (7) |
19 (40) |
|
| Washington, DC |
93 |
1 (2) |
0 |
15 (16) |
31 (33) |
35 (38) |
6 (7) |
41 (46) |
|
| Indianapolis, IN |
36 |
0 |
0 |
3 (8) |
15 (42) |
18 (50) |
0 |
18 |
(50) |
| Detroit, MI |
18 |
0 |
0 |
3 (17) |
4 (22) |
3 (17) |
2 (11) |
5 (28) |
|
| Cleveland, OH |
6 |
0 |
0 |
0 |
1 (17) |
1 (17) |
0 |
1 (17) |
|
| Milwaukee, WI |
15 |
0 |
0 |
2 (13) |
3 (20) |
3 (20) |
1 (7) |
4 (27) |
|
| Stanford, CA |
24 |
0 |
0 |
1 (4) |
4 (17) |
3 (13) |
1 (4) |
4 (17) |
|
| New York, NY | 22 | 0 | 0 | 2 (9) | 1 (5) | 3 (14) | 0 | 3 (40) | |
aN = 347; HARP, Helicobacter pylori Antimicrobial Resistance Monitoring Project.


